ArticleJHEP reports : innovation in hepatology2025

Cystic fibrosis liver disease progression in the era of elexacaftor-tezacaftor-ivacaftor.

Charlotte Mouliade et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.